CKD 498
Alternative Names: CKD-498Latest Information Update: 24 Jul 2024
At a glance
- Originator Chong Kun Dang
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Alopecia
Most Recent Events
- 20 Dec 2022 Phase-II clinical trials in Alopecia (In adults) in South Korea (PO) (NCT05677438)